Thyrocare Technologies Hits New 52-Week High of Rs. 1613.9

Thyrocare Technologies has reached a significant milestone by hitting a new 52-week high of Rs. 1613.9 on November 17, 2025. This achievement underscores the company's strong performance in the healthcare services sector, particularly as it has demonstrated a remarkable 58.79% increase in stock value over the past year, significantly outperforming the Sensex, which has only risen by 9.22% during the same period.
The stock has shown consistent upward momentum, gaining 15.7% over the last five days alone. Today, it opened with a notable gain of 3.16%, reflecting positive market sentiment. Thyrocare Technologies is currently trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a robust market position.

Despite underperforming its sector by 0.81% today, the company has reported impressive financial metrics, including a high return on equity (ROE) of 23.66% and a significant net profit growth of 77.95% in its latest quarterly results. With a solid track record of positive results over the last seven quarters, Thyrocare Technologies continues to establish itself as a strong player in the small-cap healthcare market.